The Austin Technology Incubator (ATI) is the deep technology incubator of UT Austin. We nurture startups founded around scientific and engineering breakthroughs, particularly in healthcare and sustainability. For over 30 years ATI has served UT faculty, researchers, and students at many stages in their entrepreneurship journey with programs including ATI membership, NSF I-Corps, Texas Global Health Security Innovation Consortium, TEX Venture Mentoring Service, and Student Associate experiences.

The Business Research Center which is a virtual resource is designed to connect students, faculty, and staff to the business databases available for research at UT.

The Center for Additive Manufacturing and Design Innovation houses a number of high-end, commercial additive manufacturing (AM) machines. We are capable of fabricating complex polymer and metal parts using our core technology platforms: Direct Metal Laser Sintering (DMLS), Selective Laser Sintering (SLS), Stereolithography (SLA), and PolyJet (PJ). These systems can be used for prototyping as well as producing functional, end-use components in small lot sizes.

The Texas Performing Arts Fabrication Studios are a fully staffed production facility and learning laboratory. We construct scenic elements, painted backdrops, theatrical properties, displays, and installations for funded projects. We co-design projects with UT faculty, staff, and student organizations and fabricate with our professional staff and paid student interns.

The Kendra Scott Women’s Entrepreneurial Leadership Institute (KS WELI) supports creatives, founders, leaders, and allies by redefining leadership and entrepreneurship. KS WELI equips and empowers students of all backgrounds through engaging programming and events, spotlighting women-led businesses through the FoundHER Program, and sponsoring interdisciplinary courses within the McCombs Entrepreneurship Minor. Since its founding, KS WELI has become a force on UT’s campus to grow and support the number of women-owned and women-led businesses.

Texas Momentum is a student organization on a mission to create a vibrant entrepreneurship community for students. We run a semester-long startup accelerator that connects student-founders with product managers, software engineers, and designers to build, launch, and scale their venture. Membership in Momentum is open to all majors.

The Office of Industry Engagement (OIE) negotiates all contracts related to private industry research funding. OIE endeavors to streamline negotiations to better accommodate industry financial cycles and assist UT faculty in their collaborative efforts with industry partners. OIE focuses on flexible engagements and expedited contractual negotiations, through collaboration with internal and external stakeholders and with support from the Office of Technology Commercialization.

The Office of Technology Commercialization (OTC) is the only organization on campus authorized to manage university-owned IP (trademarks excepted). The OTC works with researchers to define the technology, assess its development stage, strategize potentially valuable patent claims, and as necessary, file patents to protect the IP in advance of publication. The OTC also supports technologies that are not patentable, such as software and copyrighted works that may be commercialized via license.

The Texas Global Health Security Innovation Consortium (TEXGHS) connects academic, public- and private-sector partners to support companies working towards pandemic preparedness and response in Texas. TEXGHS is developing a health security innovation ecosystem that supports innovators and innovations fighting COVID-19 and future pandemics. UT Austin entrepreneurs should contact TEXGHS when they are seeking to commercialize infectious disease-related innovations at any stage of development.

Texas Health Catalyst supports the translation of promising ideas and discoveries into solutions that improve health outcomes and lower health care costs. The program provides support through timely and customized guidance on the research and development pathway from industry and clinical experts (Phase 1 awards), as well as seed funding for awardees (Phase 2 awards of $5K-$50K per project).